Delivery Order HHSF223201610027I-HHSF22301002T
Award Date
9/23/16
Potential Completion Date
9/29/17
Potential Value
$94K
Federal Agency
Food and Drug Administration
Awardee
Inflexxion, Inc.
Ultimate Awardee
Not listed
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
NEWTON U F, MA 02464, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order task order awarded by the Food and Drug Administration (FDA) to Inflexxion, Inc. for a "DATA RESOURCE FOR POST-MARKETING PRESCRIPTION AND OVER-THE-COUNTER DRUG ABUSE SURVEILLANCE DATA FROM INDIVIDUALS ENTERING OR BEING ASSESSED FOR SUBSTANCE ABUSE TREATMENT SUMMARY REPORTS." The task order is part of the FDA Prescription Drug Abuse Summary Reports contract vehicle. The award has a ceiling value of $805,497.01 and was made on September 20, 2016,...
This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $1,024,971 contract is for data resources and surveillance reports to support post-marketing monitoring of non-medical use of pharmaceuticals and illicit drug use. The contract has a six-month performance period with a completion date of September 29, 2026. This delivery order is part of a larger $10 million FDA indefinite...
The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
This is a $1,467,579.00 delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health) on September 20, 2019. The contract is titled "IMPROVING THE QUALITY AND REPRESENTATIVENESS OF THE TREATMENT CENTER PROGRAM DATA" and has a completion date of March 15, 2025. The contract is a Firm Fixed Price type with no set-aside designation. It is issued under the FDA...
The U.S. Food and Drug Administration (FDA) awarded a $137,779.00 firm fixed price purchase order contract to Institutes For Behavior Resources, Inc., a non-profit organization, for the CENTER FOR DRUG EVALUATION AND RESEARCH ADMINISTRATIVE MANAGEMENT PROGRAM (OEP) AND HUMAN DRUGS PROGRAM (OCD). The contract supports work in Baltimore, MD and has an ultimate completion date of October 30, 2025. It was awarded on April 19, 2024 and does not have a set-aside designation. Institutes For Behavior...
This is a federal contract awarded by the Department of Health and Human Services' Food and Drug Administration to the Denver Health and Hospital Authority. The $427,972.40 contract is for a "DATA ENHANCEMENT PROJECT" to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance data. The work is being performed under the FDA Prescription Drug Abuse Summary Reports contract vehicle. The contract does not have a set-aside designation. As a U.S. local...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price definitive contract worth $595,345.32 to Mark Herring Associates, Inc., a for-profit organization and Subchapter S Corporation. The contract is for a two-phase project, with Phase One involving the collection, analysis, interpretation, and reporting of qualitative data from approximately 140 individuals who have used prescription opioids and at least one of four other substances. The work...
The Department of Health and Human Services, Food and Drug Administration (FDA) awarded a $20,228,255.16 firm fixed price delivery order to Source Healthcare Analytics LLC's SHS Division, a foreign-owned, self-certified small disadvantaged business. The delivery order, issued under a $45 million single-award Indefinite Delivery Contract, provides the FDA access to outpatient prescription and patient-level drug utilization data over a five-year period to support the agency's drug safety...
The Food and Drug Administration (FDA) awarded a $6,842,784 firm-fixed-price purchase order contract to S-3 Research LLC, a minority-owned small disadvantaged business, to provide Internet Monitoring Services. The contract supports the FDA's efforts to counter the widespread illicit trafficking and marketing of FDA-regulated products online, including prescription drugs, dietary supplements, tobacco, medical devices, and more. The contract has a base period of one year with four one-year...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Source Healthcare Analytics LLC, a global provider of outsourced development services to the pharmaceutical and medical device industries. The $140,032 contract is for access to prescription and non-retail sales data by geography, to support the FDA's monitoring of drug safety and effectiveness during the national health emergency. This award is associated with a larger $45...